STOCK TITAN

Vanguard disaggregates holdings; reports 0% in Incyte (INCY)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Incyte Corp Schedule 13G/A amendment reports that The Vanguard Group holds 0% of Incyte common stock, with 0 shares beneficially owned as of the filing. The amendment explains an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries to report ownership separately in reliance on SEC Release No. 34-39538.

The filing is signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings, reporting zero beneficial ownership for the parent entity.

The amendment documents an internal reorganization at The Vanguard Group dated January 12, 2026, after which certain subsidiaries report holdings separately under SEC Release No. 34-39538. The filing lists 0 shares and 0% beneficial ownership for the parent entity.

Impact depends on subsidiary-level filings; subsequent disclosures will show where holdings migrated and any voting/dispositive control retained by affiliate entities.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does The Vanguard Group's Schedule 13G/A for INCY report?

It reports 0 shares and 0% beneficial ownership for The Vanguard Group in Incyte. The amendment cites an internal realignment on January 12, 2026 and reliance on SEC Release No. 34-39538 for disaggregated reporting.

Why did Vanguard report zero ownership in the INCY amendment?

Because of an internal realignment on January 12, 2026, Vanguard states that subsidiaries now report beneficial ownership separately under SEC Release No. 34-39538, leaving the parent entity with 0 shares reported here.

Does the INCY filing say Vanguard subsidiaries still hold shares?

The filing says certain subsidiaries or business divisions will report beneficial ownership separately and pursue the same strategies; it does not list subsidiary share counts in this amendment and shows 0 shares for the parent entity.

Who signed the INCY Schedule 13G/A amendment for Vanguard?

The Schedule 13G/A amendment is signed by Ashley Grim, Head of Global Fund Administration, with the signature date shown as 03/27/2026 on the filing.

Does this amendment change Vanguard's voting or dispositive power in INCY?

The amendment lists 0 for sole and shared voting and dispositive power for the parent entity. Any voting or dispositive power now attributable to subsidiaries is not disclosed in this specific amendment.
Incyte Corp

NASDAQ:INCY

View INCY Stock Overview

INCY Rankings

INCY Latest News

INCY Latest SEC Filings

INCY Stock Data

18.36B
194.97M
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
WILMINGTON